{
  "id": "411fe7786949",
  "type": "finding",
  "topic": "Zepbound quarterly revenue history",
  "summary": "Complete Zepbound global revenue Q1 2024 - Q3 2025",
  "content": "Zepbound Global Revenue (millions USD):\n- Q1 2024: $517.4M\n- Q2 2024: $1,243.3M\n- Q3 2024: $1,257.8M\n- Q4 2024: $1,907.2M\n- Q1 2025: $2,311.9M\n- Q2 2025: $3,381.4M\n- Q3 2025: $3,588.1M\n\nTotal 2024: $4,925.7M\nTotal Q1-Q3 2025: $9,281.4M\n\nSequential growth Q4 vs Q3 2024: 51.6%\nYoY growth rates:\n- Q1 2025/Q1 2024: 347%\n- Q2 2025/Q2 2024: 172%\n- Q3 2025/Q3 2024: 185%",
  "sources": [
    "https://www.statista.com/statistics/1636037/eli-lilly-zepbound-revenue/",
    "https://investor.lilly.com/news-releases/news-release-details/lilly-reports-third-quarter-2025-financial-results-highlights-rd"
  ],
  "confidence": 0.95,
  "question_id": 41976,
  "report_path": "",
  "created_at": "2026-02-07T03:45:16.836949Z"
}